期刊文献+

藤黄酰甘氨酸的合成及体外抗肿瘤活性测试 被引量:1

Synthesis and Biological Evaluation of Gambogoyl Glycine as Anticancer Agent
下载PDF
导出
摘要 以藤黄酸和甘氨酸甲酯为原料,采用N-乙基-N-二甲胺基丙基碳二亚胺(EDCI)法合成藤黄酰甘氨酸甲酯,再经水解得到藤黄酰甘氨酸。目标化合物的化学结构经红外光谱、核磁共振氢谱及质谱确证。考察了反应溶剂、反应温度、反应液pH值三个因素对水解反应产率的影响,优选出最佳合成工艺。最佳合成工艺为:反应溶剂为丙酮-水体系、反应温度25~30℃、反应液pH值为10~11。藤黄酰甘氨酸收率达70%(以藤黄酸计)。采用溴化噻唑蓝四氮唑(MTT)法测试目标物的体外抗肿瘤活性,结果表明,藤黄酸酰甘氨酸具有很好的抗肿瘤作用。 In order to search for new compound with higher anti-tumor activity and lower toxicity, glycine conjugate of gambogic acid was designed and synthesized. Gambogoyl glyeine was gained by. coupling the corresponding glyein methylate to the 30-COOH of gambogic acid and subsequent deacetylation. The effect of solvent, reaction temperature and pH on the yield of gambogoyl glycine was studied. The optimum reaction conditions were as follows : acetone-water as the solvent; keeping temperature at 25-30℃; and pH= 10 - 11. The yield of the target compound was 70%. The biological evaluation showed that gambogoyl glyeine had stronger cytotoxic activities than gambogic acid against human hepatoma cells BEL- 7402 in vitro by MTT method.
出处 《化学世界》 CAS CSCD 北大核心 2012年第4期228-231,共4页 Chemical World
基金 安徽省教育厅自然科学重点科研项目(KJ2010A204) 安徽省教育厅自然科学基金项目(KJ2009B165)
关键词 藤黄酸 甘氨酸甲酯 抗肿瘤 gambogic acid glycin methylate antieancer
  • 相关文献

参考文献9

  • 1Kartha G etal. Tetrahedron[J].1965,21:1453.
  • 2WuZQ, Guo QL, You QD, etal. ChinJ Nat Med [J]. 2003, (1): 99-102.
  • 3Guo Q L, Lin S S, You Q D, et al. Life Sci [J]. 2006, 78: 1238-1245.
  • 4Zhang J , Zhang X, Wang Y Q, et al. Pract J Cancer [J]. 2003, 18: 9-10.
  • 5Lu N, Yang Y , You QD, etal. Cancer Letters [J]. 2007, 258: 80-89.
  • 6Kobayashi K, Ohnishi A, Promsuk Neurosurgery [J]. 2008, 62(2): 493-503.
  • 7Asano S, Kameyama M, Oura A, et al. Bull [J]. 2007, 30(3): 411- 422.
  • 8Bid Pharm Moreira D R M, Leite A C L, Ferreira D M P, etal Eur J Med Chem [J]. 2007,42(3): 351.
  • 9冯锋,柳文媛,陈优生,郭青龙,尤启冬.藤黄酸衍生物的研究[J].中国药科大学学报,2005,36(4):302-305. 被引量:7

二级参考文献7

  • 1雷秋模 刘金妹.藤黄(总体)抗癌实验与临床研究报告[J].江西医药,1983,15(3):1-5.
  • 2陈葆仁.藤黄抗癌成分的研究[J].江西医学院学报,1980,(2):1-7.
  • 3Jun AA, Kazuhiro CB, Masahiro TD, et al. Cytotoxic xanthones from Garcinia hanburyi [ J ] . Phytochemistry , 1996,41 (3): 815 - 820.
  • 4Lin LJ, Lin LZ, John MP, et al. Isogambogic acid and isomorellinol from Garcinia hanburyi [ J ]. Magn Reson Chem , 1993,31: 340 - 347.
  • 5Cao SG, Valefie HLS, Wu XH, et al. Novel cytotoxic polyprenylated xanthonoids from Garcinia gaudichaudii ( Guttiferae ) [ J ].Tetrahedron,1998,54:10 915 - 10 924.
  • 6Cao SG, Wu XH, Sim KY, et al. Cytotoxic caged tetraprenylated xanthonoids from Garcinia gaudichaudii ( Guttiferae ) [ J ].Tetrahedron, 1998,39:3 353 - 3 356.
  • 7郭青龙,赵丽,尤启冬,吴照球,顾红燕.藤黄酸诱导人胃腺癌SGC-7901细胞的凋亡作用(英文)[J].中国天然药物,2004,2(2):106-110. 被引量:26

共引文献6

同被引文献11

  • 1Roses P, Carbajo D, Sanclimens G, et al. Cell-penetrating -peptide/antimicrobial undecapeptide conjugates with anticancer activity [J]. Tetrahedron, 2012, 68(23): 4406-4412.
  • 2Riedl S, Zweytick D, Lohner K. Membrane-active host defense peptides-challenges and perspectives for the development of novel anticancer drugs[J]. Chemistry and Physics of Lipids, 2011,164(8): 766-781.
  • 3Friedrichsen G.M, Nielsen C.U., Steffansen B. et al. Model prodrugs designed for the intestinal peptide transporter. A synthetic approach for coupling of hydroxy-containing compounds to dipeptides[J]. Eur J Pharm Sci, 2001, 14:13-19.
  • 4Nielsen C U, Andersen R, Brodin B, et al. Model prodrugs for the intestinal oligopeptide lransporter: model drug release in aqueous solution and in various biological media [J]. J Control Release, 2001, 73:21-30.
  • 5Nielsen C U, Andersen R, Brodin B, et al. Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line [J]. J Control Release, 2001, 76: 129-138.
  • 6Bailey P D, Boyd C A R, Bronk J R, et al. How to Make Drugs Orally Active: A Substrate Template for Peptide Transporter PepT1 [J]. Angew. Chem. Int. Ed, 2000, 39(3):515-518.
  • 7余佳,吴晓晴,孙海峰,吉民.大黄酸及其衍生物的生物活性研究进展[J].药学与临床研究,2008,16(2):125-128. 被引量:33
  • 8刘彦珠,罗国安,沈子威.大黄素、大黄酸对平滑肌细胞增殖抑制作用研究[J].生物物理学报,1998,14(2):240-244. 被引量:20
  • 9李晓红,李蒙,陶艳蓉.大黄酸及其衍生物药理作用研究新进展[J].现代药物与临床,2010,25(6):417-421. 被引量:49
  • 10郭美姿,徐海荣,李孝生.大黄酸对小鼠急性肝损伤的影响[J].中医药研究,2002,18(1):37-38. 被引量:34

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部